Cart
sales@molnova.com
Home - Products - Angiogenesis - FGFR - FIIN-4

FIIN-4

CAS No. 2093088-81-2

FIIN-4( —— )

Catalog No. M34253 CAS No. 2093088-81-2

FIIN-4 is a covalent inhibitor of FGFR and can be used in studies about metastatic breast cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 299 Get Quote
5MG 455 Get Quote
10MG 620 Get Quote
25MG 911 Get Quote
50MG 1224 Get Quote
100MG 1575 Get Quote
200MG 2133 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    FIIN-4
  • Note
    Research use only, not for human use.
  • Brief Description
    FIIN-4 is a covalent inhibitor of FGFR and can be used in studies about metastatic breast cancer.
  • Description
    FIIN-4 is a small molecule cysteine-targeting covalent kinase inhibitor (CKI).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    FGFR
  • Recptor
    FGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2093088-81-2
  • Formula Weight
    634.73
  • Molecular Formula
    C35H38N8O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N1C=2C(CN(C1=O)C3=CC(OC)=CC(OC)=C3)=CN=C(NC4=CC=C(C=C4)N5CCN(C)CC5)N2)C6=CC(NC(C=C)=O)=CC=C6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Erdafitinib

    Erdafitinib (JNJ-42756493) is a highly potent and selective, small-molecule inhibitor of FGFR family.

  • EBE-A22

    EBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.

  • ML348

    ML348 is a selective and reversible lysophospholipase 1 (LYPLA1) inhibitor (IC50 = 210 nM).

Sign In Join Free